Crescent Biopharma (CBIO) Share-based Compensation Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.70% |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | 234.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 234.66% |
| Dec 31, 2025 | 318.43% |
| Sep 30, 2025 | 2,778.26% |
| Jun 30, 2025 | 342.30% |
| Mar 31, 2025 | 3.10% |
| Dec 31, 2024 | 24.84% |
| Sep 30, 2024 | -92.23% |
| Jun 30, 2024 | 40.70% |
| Mar 31, 2024 | 36.99% |
| Dec 31, 2023 | 1.02% |
| Sep 30, 2023 | -2.86% |
| Jun 30, 2023 | -10.96% |
| Mar 31, 2023 | -19.48% |
| Dec 31, 2022 | -31.88% |
| Sep 30, 2022 | -42.55% |
| Jun 30, 2022 | -38.31% |
| Mar 31, 2022 | -33.05% |
| Dec 31, 2021 | -18.89% |
| Sep 30, 2021 | -5.89% |
| Jun 30, 2021 | -11.33% |
| Mar 31, 2021 | -11.41% |
| Dec 31, 2020 | -5.71% |
| Sep 30, 2020 | 6.50% |
| Jun 30, 2020 | 15.95% |
| Mar 31, 2020 | 31.81% |
| Dec 31, 2019 | 50.13% |
| Sep 30, 2019 | 35.52% |
| Jun 30, 2019 | 32.08% |
| Mar 31, 2019 | 23.89% |
| Dec 31, 2018 | 19.21% |
| Sep 30, 2018 | 21.69% |
| Jun 30, 2018 | 16.07% |
| Mar 31, 2018 | 32.39% |
| Dec 31, 2017 | 32.83% |
| Sep 30, 2017 | 30.15% |
| Jun 30, 2017 | 28.43% |
| Mar 31, 2017 | 15.85% |
| Dec 31, 2016 | 12.59% |
| Sep 30, 2016 | 16.82% |
| Jun 30, 2016 | 68.41% |
| Mar 31, 2016 | 23.83% |
| Dec 31, 2015 | 33.63% |
| Sep 30, 2015 | 43.27% |
| Jun 30, 2015 | 9.51% |
| Mar 31, 2015 | 101.05% |
| Dec 31, 2014 | 696.33% |
| Sep 30, 2014 | 199.70% |
| Jun 30, 2014 | 281.56% |
| Mar 31, 2014 | 170.54% |